# Danazol for Treatment of Cytopenias in Patients With Cirrhosis

> **NCT04873102** · PHASE2 · RECRUITING · sponsor: **University of Southern California** · enrollment: 10 (estimated)

## Conditions studied

- Cirrhosis, Liver
- Cytopenia

## Interventions

- **DRUG:** Danazol Pill

## Key facts

- **NCT ID:** NCT04873102
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2027-08-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04873102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04873102, "Danazol for Treatment of Cytopenias in Patients With Cirrhosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04873102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*